Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2000; 46(5): 83-93


Role of Apoptosisin Pathogenesis of Atherosclerosis

Byts Yu. V., Dosenko V. E., Medvedev V. V.

    A.A. Bogomolets National Medical UniversityMinistry of Public Health of Ukraine, Kiev


Abstract

The recent information about importance of programmed cell death in the development of atherosclerosis was reviewed. It was emphasized, that intensiveness of apoptosis was various for smooth muscle cells, macrophages, endothelial cells, lymphocytes, and changed during the development of such a multistage process as atherosclerosis. Is was proved, that exactly apoptosis gave specific features to the atherosclerotic process. The agents inducing atherosclerosis (modified lipoprotein, mechanical influences, viruses, bacterial toxins, etc.), have unsufficient for initiation of necrosis. The damage to vascular wall in atherosclerosis is characterized not by intensive influence of pathogenic factors, but rather constant chronic influence of the agents of moderate power. Therefore, it is just apoptosis that makes up the critical mechanism of the reactive-regeneration answer of vascular wall structures to an injure. Evolutionaly, the apoptic way of the development of answer to an injure appears to be more rational, as for as it results in minimal losses of cells due to both secondary alteration and maintenance of fast restoration of the primary cellular architecture of injured tissues at the expense of the natural mechanisms of regulation of apoptosis and proliferation. In the certain situation, these positive aspects of apoptosis make up a basis for the development of a pathology — failures in the program of apoptosis result in chronic proliferative-degenarative processes, that is in atherosclerosis.

References

  1. Атаман А.В. Энергообеспечение артерий и вен в связи с их разной устойчивостью кдействию повреждающих факторов: Автореф. дис. ... д-ра мед. наук. — Киев, 1991. —25 с.
  2. Быць Ю.В. Роль нарушений метаболизма сосудистой стенки в процессе ее склерози-рования: Автореф. дис. ... д-ра мед. наук.: — К., 1973. — 44 с.
  3. Биць Ю.В., Досенко В.Є. Роль еластази в патогенезі артеріосклерозу // Проблемымедицины. — 1999. — №5. — С.10-17.
  4. Досенко В.Є. Активність еластази та її інгібіторів у тканинах артерій та сироватцікрові за умов експериментального артеріо-атеросклерозу // Укр. биохим. журн. —1998. — 70, №4. — С.88-94.
  5. Нагорнев В.А. Атерогенез и иммунное воспаление // Арх. патологии. — 1995. —57, №3. — С.6-14.
  6. Фильченков А.А., Стойка Р.С. Апоптоз (физиологическая смерть клетки). К.: Ви-тус, 1995. — 24 с.
  7. Цыпленкова В.Г., Бескровнова Н.Н. Апоптоз // Арх. патологии. — 1996. — №5. —С.71-74
  8. Ярилин А.А. Апоптоз. Природа феномена и его роль в целостном организме //Патол. физиология и эксперим. терапия. — 1998. — С.38-48.
  9. 9. Barnes M.J., Knight C.G., Farndale R.W. Collagens and atherosclerosis: cell-collageninteraction. — In.: Atherosclerosis XI Eds. Jacotot B., Mathe D., Fruchart J.-C. —Elsevier Science, 1998. — P.299-306.
  10. 10. Barry W.L., Gimple L.W., Humphries J.E. et al. Arterial thrombin activity afterangioplasty in an atherosclerotic rabbit model // Circulat Con. — 1996. — 94. —P.88-93.
  11. Bauriedel G., Schluckebier S., Hutter R. et al. Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis // Arterioscler.Thromb. Vasc. Biology. — 1998. — 18, №7. — P.1132-1139.
  12. Benditt E.P., Benditt J.M. Evidence for a monoclonal origin of human atheroscleroticplaques // Proc. Nat. Acad. Sci. USA. — 1973. — 70. — P.1753-1756.
  13. Bennett M.R., Evan G.I., Schwartz S.M. Apoptosis of human vascular smooth musclecells derived from normal vessels and coronary atherosclerotic plaques // J. Clin.Invest. — 1995. — 95, №5. — P.2266-2274.
  14. Bennett M.R., Littlewood T.D., Schwartz S.M., Weissberg P.L. Increased sensitivityof human vascular smooth muscle cells from atherosclerotic plaques to p53-mediatedapoptosis // Circulat. Res. 1997. — 81, №4. — P.591-599.
  15. Bennett M.R., Macdonald K., Chan S.W., Boyle J.J., Weissberg P.L. Cooperativeinteractions between RB and p53 regulate cell proliferation, cell senescence, and apoptosisin human vascular smooth muscle cells from atherosclerotic plaques // Wbid. —1998. — 82, №6. — P.704-712.
  16. Bobryshev Y.V., Babaev V.R., Lord R.S., Watanabe T. Cell Death in atheromatousplague of the carotid artery occurs through necrosis rather than apoptosis // In Vivo. —1997. — 11, №6. — P.441-452.
  17. Corjay M.H., Kearney M.A., Munzer D.A. et al. Antiproliferative gene BTG1 ishighly expressed in apoptotic cells in macrophage-rich areas of advanced lesions inWatanabe heritable hyperlipidemic rabbit and human // Lab. Invest. — 1998. — 78,№7. — P.847-858.
  18. Crisby M., Kallin B., Thyberg J. Cell death in human atherosclerotic plaques involvesboth oncosis and apoptosis // Atherosclerosis. — 1997. — 130, №1-2. — P.17-27.
  19. 19. Davies M.J. Apoptosis in cardiovascular disease // Heart. — 1997. — 77, №6. —P.498-501.
  20. 20. Dimmeler S., Breitschopf K., Haendeler J. et al. Dephosphorylation targets Bcl-2 forubiquitin-dependent degradation: a link between the apoptosome and the proteasomepathway // Exp. Med. — 1999. — 189, №11. — P.1815-1822.
  21. Duhamel-Clerin E., Orvain C., Lanza F. et al. Thrombin receptor-mediated increase oftwo matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells //Arterioscler. Thromb. Vasc. Biol. — 1997. — 17, №10. — P.1931-1938.
  22. Flynn P.D., Byrne C.D., Baglin T.P. et al. Thrombin generation by apoptotic vascularsmooth muscle cells // Blood. — 1997. — 89, №12. — P.4378-44384.
  23. Forough R., Lea H., Starcher B. et al. Metalloproteinase blockade by local overexpressionof TIMP-1 increases elastin accumulation in rat carotid artery intima // Arterioscler.Thromb. Vasc. Biol. — 1998. — 18, №5. — P.803-807.
  24. Fukuo K., Nakahashi T., Nomura S. et al. Possible participation of Fas-mediatedapoptosis in the mechanism of atherosclerosis // Gerontology. — 1997. — 43, Suppl 1.—P.35-42.
  25. Geng Y.J. Regulation of programmed cell death or apoptosis in atherosclerosis //Heart and Vessels. — 1997, Suppl 12. — P.76-80.
  26. Geng Y.J., Henderson L.E., Levesque E.B. et al. Fas is expressed in human athero-sclerotic intima and promotes apoptosis of cytokine-primed human vascular smoothmuscle cells // Arterioscler. Thromb. Vasc. Biology. — 1997. — 17, №10. — P.2200-2208.
  27. Geng Y.J., Libby P. Evidence for apoptosis in advanced human atheroma. Colocalizationwith interleukin-1 beta-converting enzyme // Amer. J. Pathology. — 1995. — 147,№2. — P.251-266.
  28. Harada K., Chen Z., Ishibashi S. et al. Apoptotic cell death in atherosclerotic plaquesof hyperlipidemic knockout mice // Atherosclerosis. — 1997. — 135, №2. — P.235-239.
  29. 29. Hegyi L., Hardwick S.J., Mitchinson M.J., Skepper J.N. The presence of apoptoticcells in human atherosclerotic lesions // Amer. J. Pathology. — 1997. — 150, №1. —P.371-373.
  30. 30. Hegyi L., Skepper J.N., Cary N.R., Mitchinson M.J. Foam cell apoptosis and thedevelopment of the lipid core of human atherosclerosis // J. Pathology. — 1996. —180, №4. — P.423-429.
  31. Holmes D.R., Lopez-Candales A., Liao S. Thompson R.W. Smooth muscle cell apoptosisand p53 expression in human abdominal aortic aneurysms // Ann. NY Acad. Sci. —1996. — 800. — P.286-287.
  32. Isner J.M., Kearney M., Bortman S., Passeri J. Apoptosis in human atherosclerosisand restenosis // Circulation. — 1995. — 91, №11. — P.2703-2711.
  33. Kerr J.F.R., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon withwide ranging implications in tissue kinetics // Brit. J. Cancer. — 1972. — 26. —P.239-257.
  34. Kim Y.M., Bombeck C.A., Billiar T.R. Nitric oxide as a bifunctional regulator ofapoptosis // Circulat. Res. — 1999. — 84. — P.253-256.
  35. Kinscherf R., Deigner H.P., Usinger C. et al. Induction of mitochondrial manganesesuperoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosisof humans and heritable hyperlipidemic rabbits // FASEB J. — 1997. — 11, №14. —P.1317-1328.
  36. Kockx M., De Meyer G. Apoptosis in human atherosclerosis and restenosis //Circulation. — 1996. — 93, №2. — P.394-395.
  37. Kockx M.M., De Meyer G.R., Buyssens N. et al. Cell composition, replication, andapoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal // Circulat.Res. — 1998. — 83, №4. — P.378-387.
  38. Kockx M.M., De Meyer G.R., Muhring J. et al. Apoptosis and related proteins indifferent stages of human atherosclerotic plaques // Circulation. — 1998. — 97,№23. — P.2307-2315.
  39. 39. Kockx M.M., De Meyer G.R., Muhring J. et al. Distribution of cell replication andapoptosis in atherosclerotic plaques of cholesterol-fed rabbits // Atherosclerosis. —1996. — 120, №1-2. — P.115-124.
  40. 40. Kockx M.M., Muhring J., Knaapen M.W., de Meyer G.R. RNA synthesis and splicinginterferes with DNA in situ end labeling techniques used to detect apoptosis // Amer.J. Pathology. — 1998. — 152, №4. — P.885-888.
  41. Konstadoulakis M.M., Kymionis G.D., Karagiani M. et al. Evidence of apoptosis inhuman carotid atheroma // J. Vasc. Surgery. — 1998. — 27, №4. — P.733-739.
  42. Labat-Robert J., Kern P., Robert L. Biomarkers of connective tissue aging: biosynthesisof fibronectin, collagen type III, and elastase [Review] // Ann. NY Acad. Sci. —1992. — 673. — P.16-22.
  43. Lysiak J.J., Hussaini I.M., Webb D.J. et al. Alpha 2-macroglobulin function as acytokine carrier to induce nitric oxide syntesis and cause nitric oxide-dependentcytotoxicity in the RAW 264.7 macrophage cell line // J. Biol. Chem. — 1995. —270, №37. — P.21919-21927.
  44. Mallat Z., Ohan J., Leseche G., Tedgui A. Colocalization of CPP-32 with apoptoticcells in human atherosclerotic plaques // Circulation. — 1997. — 96, №2. — P.424-428.
  45. Maruyama I., Shigeta K., Miyahara H. et al. Thrombin activates NF-kappa B throughthrombin receptor and results in proliferation of vascular smooth muscle cells: role ofthrombin in atherosclerosis and restenosis // Ann. N Y Acad. Sci. — 1997. — 811. —P.429-36.
  46. McCormick T.S., Lapetina E.G. Documentation of efficacy of drugs affecting apoptosisand other atheroma-related mechanisms // Amer. J. Cardiology. — 1998. — 81,№8A. — P.48F-49F.
  47. Mitchinson M.J., Hardwick S.J., Bennett M.R. Cell death in atherosclerotic plaques// Curr. Opinion Lipidology. — 1996. — 7, №5. — P.324-329.
  48. Rembold C. Could atherosclerosis originate from defective smooth muscle cell death(apoptosis)? // Perspect. Biol. and Med. — 1996. — 39, №3. — P.405-408.
  49. 49. Ross R. New insights into the mechanisms of atherosclerosis. — In.: Atherosclerosis XI/ Eds. Jacotot B., Mathe D., Fruchart J.-C. — Elsevier Science, 1998. — P.299-306.
  50. 50. Ross R. The pathogenesis of atherosclerosis — an update // N. Eng. J. Med. —1986. — 314, №8. — P.488-498.
  51. Stempien-Otero A., Karsan A., Cornejo C.J. Mechanisms of hypoxia-induced endothelialcell death. Role of p53 in apoptosis // J. Biol. Chem. — 1999. — 274, №12. —P.8039-8045.
  52. Takeya H., Tanaka Y., Suzuki K. Thrombosis and apoptosis // Jap. J. Clin. Patholo-gy. — 1997. — 45, №7. — P.614-620.
  53. Yang X., Galeano N.F., Szabolcs M. et al. Oxidized low density lipoproteins altermacrophage lipid uptake, apoptosis, viability and nitric oxide synthesis // J. Nutri-tion. — 1996. — 126, №4 (Supp.l). — P.1072S-1075S.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2018.